Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea is a research paper published in JNCI Journal of the National Cancer Institute (2020). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Clinical and Translational Science Awards
Grant: KL2TR000136-09
Clinical and Translational Science Awards
Grant: KL2TR002379
National Institutes of Health
Grant: U10CA180868
National Institutes of Health
Grant: U10CA180822
National Institutes of Health
Grant: U24CA196067
National Institutes of Health
Grant: UG1-189867
National Institutes of Health
Grant: U10CA180820
National Institutes of Health
Grant: U10CA21115
National Institutes of Health
Grant: R01CA225662
National Institutes of Health
Grant: P50CA116201
NCI NIH HHS
Grant: UG1 CA189867
NCATS NIH HHS
Grant: KL2 TR000136
NCI NIH HHS
Grant: U10 CA021115
National Institutes of Health
Grant: 5KL2TR000136-09
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
National Institutes of Health
Grant: 5U10CA180868-09
NRG Oncology Network Group Operations Center
National Institutes of Health
Grant: 2U10CA180822-06
NRG Oncology - Statistical and Data Management Center
National Institutes of Health
Grant: 5U10CA021115-39
Eastern Cooperative Oncology Group Operations Office
National Institutes of Health
Grant: 3UG1CA189867-03S1
NRG Oncology NCORP Research Base
National Institutes of Health
Grant: 5KL2TR002379-09
Institutional Career Development Core
National Institutes of Health
Grant: 5U24CA196067-04
NRG Oncology Biospecimen Bank
National Institutes of Health
Grant: 5R01CA225662-05
The contribution of RAD51C and RAD51D to breast and ovarian cancer
National Institutes of Health
Grant: 5P50CA116201-08
Career Development (Ingle)
F. Hoffmann-La Roche, Ltd
Breast Cancer Research Foundation
National Center for Advancing Translational Sciences
NCI
Tracy Starr Breast Cancer Research Fund Award
FWCI
0.86
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals